stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Return on assets
Stevanato Group S.p.A.'s return on assets over the twelve months to 30 September 2026 was 5.50%, down 0.4 percentage points from fiscal 2025 (5.86%). Over the past ten years it has ranged from 5.35% (fiscal 2024) to 11.4% (fiscal 2021); the current reading is higher than 29% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 5.86% | 0.51 |
| FY2024 | 5.35% | (2.55) |
| FY2023 | 7.90% | (0.88) |
| FY2022 | 8.78% | (2.63) |
| FY2021 | 11.4% | 2.85 |
| FY2020 | 8.56% | (0.33) |
| FY2019 | 8.89% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| NVST Envista Holdings Corporation compare | 11.3% |
| MMSI Merit Medical Systems, Inc. compare | 5.76% |
| STVN Stevanato Group S.p.A. | 5.50% |
| ATRC AtriCure, Inc. compare | 2.20% |
| ICUI ICU Medical, Inc. compare | 1.50% |
| WRBY Warby Parker Inc. compare | 1.00% |
| MMED MiniMed Group, Inc. compare | −6.27% |
| TFX Teleflex Incorporated compare | −14.6% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement